Teamwork Financial Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,916
Closed -$234K 202
2023
Q3
$234K Sell
1,916
-243
-11% -$30.9K 0.04% 181
2023
Q2
$274K Sell
2,159
-113
-5% -$14.7K 0.04% 160
2023
Q1
$293K Buy
2,272
+392
+21% +$51.3K 0.05% 157
2022
Q4
$247K Sell
1,880
-5,052
-73% -$653K 0.05% 171
2022
Q3
$811K Buy
+6,932
New +$861K 0.17% 85
2020
Q3
Sell
-7,828
Closed -$1.07M 192
2020
Q2
$1.07M Buy
+7,828
New +$998K 0.38% 63

Other funds holding IBB

Teamwork Financial Advisors's IBB Position: Q4 2023 in Review

Teamwork Financial Advisors sold out of iShares Biotechnology ETF (IBB) in Q4 2023, closing a stake of 1,916 shares — an estimated $234K sold.

Teamwork Financial Advisors first reported a position in IBB in Q2 2020 and held it in 6 quarters. The position peaked at $1.07M in Q2 2020. 872 funds tracked by Wall St. Rank hold IBB as of Q4 2023.

  • Teamwork Financial Advisors reported no remaining iShares Biotechnology ETF position as of Q4 2023 after selling out during the quarter.
  • Teamwork Financial Advisors sold 1,916 iShares Biotechnology ETF shares in Q4 2023, an estimated $234K.
  • Teamwork Financial Advisors first reported a position in iShares Biotechnology ETF in Q2 2020 and held it in 6 quarters.
  • Teamwork Financial Advisors's iShares Biotechnology ETF position peaked at $1.07M in Q2 2020.
  • 872 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2023.

Based on Teamwork Financial Advisors's 13F filing for Q4 2023, filed 19 Jan 2024.